期刊文献+

MDM2、p53在肺腺癌中的表达及其意义

Expression and significance of MDM2 and p53 protein in lung adenocarcinoma
原文传递
导出
摘要 目的探讨MDM2蛋白、p53在肺腺癌中的表达及其在肺腺癌发生发展中的作用。方法应用免疫组化技术检测41例肺腺癌组织中MDM2、P53的表达。结果MDM2、p53在肺腺癌中的表达率分别为31.71%(13/41),53.66%(22/41);原发灶≥3.0cm者,p53表达率为33.43%±7.28%,高于<3.0cm者6.61%±1.34%,(P<0.01);原发灶≥3.0cm者,MDM2表达率为3.77%±1.13%,低于<3.0cm者24.53%±4.13%(P<0.05)。MDM2表达与突变型P53表达呈负相关性,Sperman等级相关r=-0.54,P<0.05。两者均与肺腺癌病理分型相关,标准回归系数(Beta)值分别为:MDM20.443,p530.74。结论MDM2的表达与P53的表达存在负相关。p53/MDM2存在负反馈机制,是肺腺癌发生发展的分子基础,此外,p53\MDM2各自还存在独立的作用机制。 Objectives To investigate the expression and significance of p53 and MDM2 in lung adenocarcinoma. Methods PCNA、MDM2 and P53 in 41 lung adenocarcinoma specimens were detected by immunohistochenistry. Results The incidence of MDM2 and p53 expression were 31.71% (13/41)and 53.66% (22/41).The expression level of p53 in the huge adenocarcinoma was higher than that of the small adenocarcinoma (33.43%+7.28% vs 6.61%+1.34% ),showing significant difference (P〈0.05). The expression level of MDM2 in the huge adenocareinoma was lower than that of the small adenocareinoma (3.77%+1.13% vs 24.53%+4.13% ), without significant difference(P〈0.05 ). There was a correlation between p53 and MDM2 (r=-0.54,P〈0.05). Conclusion There was a positive correlation between the expression of MDM2 and p53 expression. A negative feedback mechanism exists between p53 and MDM2,it is the molecular basis of the development of lung cancer.
出处 《中国热带医学》 CAS 2009年第12期2245-2246,共2页 China Tropical Medicine
关键词 肺腺癌 P53 MDM2 Lung adenocarcinoma p53 gene MDM2 gene
  • 相关文献

参考文献6

  • 1Buschmann T,Fuchs SY,Lee Cg,et al . SUMO-1 modification of MDM2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell, 2000,101:753-762.
  • 2Ryan KM,Phillips AC,Vousden KH. Regulation and function of the p53 tumor suppressor protein[J]. Curr Opin Cell Biol,2001,13(3): 332-337.
  • 3Lahav G,Rosenfeld N,Sigal A,et al . Dynamics of the p53-MDM2 feedback loop in individual cells[J]. Nat Genet,2004,36(2):147-150.
  • 4Marthai, Simmons, Kathleen R,et al. Analysis of complex relationships between age, p53, Epidermal Growth Factor Receptor, and survival in glioblastoma patients [ J ] . Cancer Research, 2001,61:1122-1128.
  • 5孙艳花,钟雪云,陈运贤,关弘.星形细胞瘤中Mdm2、p53的表达及调控机制探讨[J].肿瘤防治研究,2004,31(8):477-479. 被引量:14
  • 6LeBron C,Chen L,Gilkes DM,et al . Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3[J]. EMBO J,2006,22; 25(6) : 1196-1206.

二级参考文献9

  • 1Freedman DA, Wu L, Levine AJ. Functions of the MDM2 oncoprotein[J].Cell Mol Life Sci, 1999,55(1):96-107.
  • 2Sarkar C, Ralte AM, Sharma MC, et al. Recurrent astrocytic tumours-a study of p53 immunoreactivity and malignant progression[J].Br J Neurosurg, 2002,16(4):335-342.
  • 3Fult D, Brockmeyer D, Tullous MW, et al. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression[J].Cancer Res, 1992,52(3):674-679.
  • 4Michael D , Oren M. The p53-Mdm2 module and the ubiquitin system[J].Semin Cancer Biol,2003,13(1):49-58.
  • 5Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2[J].Nature, 1997, 387(6630):299-303.
  • 6Mayo LD , Dixon JE , Durden DL , et al. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy[J].J Biol Chem, 2002,277(7):5484-5489.
  • 7Chène P . Inhibiting the p53-MDM2 interaction : an important target for cancer therapy[J]. Nat Rev Cancer, 2003,3(2):102-109.
  • 8孙艳花,钟雪云.PTEN与信号转导及肿瘤[J].中国病理生理杂志,2002,18(3):326-329. 被引量:7
  • 9浣孝强,孟斌,邓卓霖,缪勇建.MDM2、p53和p21^(WAF1/CIP1)蛋白在胃癌中的表达及意义[J].广西医科大学学报,2002,19(1):35-38. 被引量:6

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部